Home
About
Overview
Sharing Data
ORCID
Help
History (58)
Patient and physician preferences for ulcerative colitis treatments in the United States.
Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation.
Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget.
Long-term Efficacy of Vedolizumab for Crohn's Disease.
See All 58 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-term Efficacy of Vedolizumab for Crohn's Disease.
Long-term Efficacy of Vedolizumab for Crohn's Disease. J Crohns Colitis. 2017 Apr 01; 11(4):412-424.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal, Humanized
Crohn Disease
Double-Blind Method
Female
Gastrointestinal Agents
Humans
Male
Quality of Life
Remission Induction
Treatment Outcome
authors with profiles
David Rubin